Bioresorbable scaffolds for the treatment of in-stent restenosis

A Randomized Comparison of a Sirolimus-Eluting Stent with a Standard Stent for Coronary Revascularization

Marie‐Claude Morice, Patrick W. Serruys, J. Eduardo Sousa et al. · New England Journal of Medicine · 2002 · 4K citations · Full text

Medicine, Cardiology, Pharmacotherapy +11

Safety and Efficacy of Sirolimus- and Paclitaxel-Eluting Coronary Stents

Gregg W. Stone, Jeffrey W. Moses, Stephen G. Ellis et al. · New England Journal of Medicine · 2007 · 1.6K citations · Full text

Medicine, Cardiology, Internal Medicine +15

A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods

Patrick W. Serruys, John A. Ormiston, Yoshinobu Onuma et al. · The Lancet · 2009 · 817 citations

Medicine, Cardiology, Surgery +14

Clinical and intravascular imaging outcomes at 1 and 2 years after implantation of absorb everolimus eluting bioresorbable vascular scaffolds in small vessels. Late lumen enlargement: does bioresorption matter with small vessel size? Insight from the ABSORB cohort B trial

Roberto Diletti, Vasim Farooq, Chrysafios Girasis et al. · Heart · 2012 · 82 citations · Full text

Medicine, Biomedical Engineering, Surgery +13

Diffuse in-stent restenosis of CYPHER® stent due to hypersensitivity reaction confirmed by pathohistological findings

Yoritaka Otsuka, Masanori Nakamura, Nobuaki Kokubu et al. · Heart and Vessels · 2011 · 15 citations

Medicine, Cardiology, Pathology +9